Prosthodontic treatment of a patient with bisphosphonate-induced osteonecrosis of the jaw using a removable dental prosthesis with a heat-polymerized resilient liner: A clinical report

Journal of Prosthetic Dentistry

Volumn 103, Issue 4, 2010, Pages 196-201

  Göllner, Matthias ^a   Holst, Stefan ^a   Fenner, Matthias ^a   Schmitt, Johannes ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; PAMIDRONIC ACID;

AGED; ARTICLE; BONE NECROSIS; BONE TUMOR; CASE REPORT; DENTURE; FEMALE; HUMAN; JAW DISEASE; METASTASIS; TOOTH EXTRACTION;

AGED; BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; DENTURE LINERS; DENTURE, PARTIAL, REMOVABLE; DIPHOSPHONATES; FEMALE; HUMANS; MANDIBULAR DISEASES; OSTEONECROSIS; TOOTH EXTRACTION;

EID: 77950230480     PISSN: 00223913     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3913(10)00052-1     Document Type: Article

References (39)

1. Miller P.D. Efficacy and safety of long-term bisphosphonates in postmenopausal osteoporosis. Expert Opin Pharmacother 4 (2003) 2253-2258
2. Coleman R.E. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12 20 Pt 2 (2006) 62432s-66249s
3. Coleman R.E. Risks and benefits of bisphosphonates. Br J Cancer 98 (2008) 1736-1740
4. Rosen L.S., Gordon D., Kaminski M., Howell A., Belch A., Mackey J., et al. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Cancer J 7 (2001) 377-387
5. Terpos E., Sezer O., Croucher P.I., García-Sanz R., Boccadoro M., San Miguel J., et al. The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network. Ann Oncol 20 (2009) 1303-1317
6. Hillner B.E., Ingle J.N., Berenson J.R., Janjan N.A., Albain K.S., Lipton A., et al. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel. J Clin Oncol 18 (2000) 1378-1391
7. Noor M., and Shoback D. Paget's disease of bone: diagnosis and treatment update. Curr Rheumatol Rep 2 (2000) 67-73
8. Rosen L.S., Gordon D., Tchekmedyian N.S., Yanagihara R., Hirsh V., Krzakowski M., et al. Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial. Cancer 100 (2004) 2613-2621
9. Smith M.R., Eastham J., Gleason D.M., Shasha D., Tchekmedyian S., and Zinner N. Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer. J Urol 169 (2003) 2008-2012
10. Rogers M.J. From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates. Calcif Tissue Int 75 (2004) 451-461
11. Hewitt C., and Farah C.S. Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review. J Oral Pathol Med 36 (2007) 319-328
12. Boivin G.Y., Chavassieux P.M., Santora A.C., Yates J., and Meunier P.J. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone 27 (2000) 687-694
13. Odvina C.V., Zerwekh J.E., Rao D.S., Maalouf N., Gottschalk F.A., and Pak C.Y. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90 (2005) 1294-1301
14. Marx R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61 (2003) 1115-1117
15. Ruggiero S.L., Mehrotra B., Rosenberg T.J., and Engroff S.L. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62 (2004) 527-534
16. Estafanía Fresco R.E., Ponte Fernández R., and Aguirre Urizar J.M. Bisphosphonates and oral pathology II. Osteonecrosis of the jaws: review of the literature before 2005. Med Oral Patol Oral Cir Bucal 11 (2006) E456-E461
17. Leite A.F., Figueiredo P.T., Melo N.S., Acevedo A.C., Cavalcanti M.G., Paula L.M., et al. Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 (2006) 14-21
18. Migliorati C.A. Bisphosphanates and oral cavity avascular bone necrosis. J Clin Oncol 21 (2003) 4253-4254
19. Pazianas M., Miller P., Blumentals W.A., Bernal M., and Kothawala P. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clin Ther 29 (2007) 1548-1558
20. Khan A.A., Sándor G.K., Dore E., Morrison A.D., Alsahli M., Amin F., et al. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol 35 (2008) 1391-1397
21. Wood J., Bonjean K., Ruetz S., Bellahcène A., Devy L., Foidart J.M., et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302 (2002) 1055-1061
22. Kos M., Kuebler J.F., Luczak K., and Engelke W. Bisphosphonate-related osteonecrosis of the jaws: A review of 34 cases and evaluation of risk. J Craniomaxillofac Surg (2009) [Epub ahead of print]
23. Bamias A., Kastritis E., Bamia C., Moulopoulos L.A., Melakopoulos I., Bozas G., et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23 (2005) 8580-8587
24. Zarychanski R., Elphee E., Walton P., and Johnston J. Osteonecrosis of the jaw associated with pamidronate therapy. Am J Hematol 81 (2006) 73-75
25. Kyrgidis A., Vahtsevanos K., Koloutsos G., Andreadis C., Boukovinas I., Teleioudis Z., et al. Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients. J Clin Oncol 26 (2008) 4634-4638
26. Marx R.E., Sawatari Y., Fortin M., and Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63 (2005) 1567-1575
27. Freiberger J.J., Padilla-Burgos R., Chhoeu A.H., Kraft K.H., Boneta O., Moon R.E., et al. Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series. J Oral Maxillofac Surg 65 (2007) 1321-1327
28. Alons K., Kuijpers S.C., de Jong E., and van Merkesteyn J.P. Treating low-and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107 (2009) e1-e7
29. Kawano F., Tada N., Nagao K., and Matsumoto N. The influence of soft lining materials on pressure distribution. J Prosthet Dent 65 (1991) 567-575
30. Kivovics P., Jáhn M., Borbély J., and Márton K. Frequency and location of traumatic ulcerations following placement of complete dentures. Int J Prosthodont 20 (2007) 397-401
31. Wagner W.C., Kawano F., Dootz E.R., and Koran III A. Dynamic viscoelastic properties of processed soft denture liners: Part I-Initial properties. J Prosthet Dent 73 (1995) 471-477
32. Taguchi N., Murata H., Hamada T., and Hong G. Effect of viscoelastic properties of resilient denture liners on pressures under dentures. J Oral Rehabil 28 (2001) 1003-1008
33. Okita N., Orstavik D., Orstavik J., and Ostby K. In vivo and in vitro studies on soft denture materials: microbial adhesion and tests for antibacterial activity. Dent Mater 7 (1991) 155-160
34. Yilmaz H., Aydin C., Bal B.T., and Ozçelik B. Effects of disinfectants on resilient denture-lining materials contaminated with Staphylococcus aureus, Streptococcus sobrinus, and Candida albicans. Quintessence Int 36 (2005) 373-381
35. Pinto J.R., Mesquita M.F., Henriques G.E., and de Arruda Nóbilo M.A. Effect of thermocycling on bond strength and elasticity of 4 long-term soft denture liners. J Prosthet Dent 88 (2002) 516-521
36. Kulak-Ozkan Y., Sertgoz A., and Gedik H. Effect of thermocycling on tensile bond strength of six silicone-based, resilient denture liners. J Prosthet Dent 89 (2003) 303-310
37. Aníl N., Hekimoglu C., Büyükbas N., and Ercan M.T. Microleakage study of various soft denture liners by autoradiography: effect of accelerated aging. J Prosthet Dent 84 (2000) 394-399
38. Madrid C., and Sanz M. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review. Clin Oral Implants Res 20 Suppl 4 (2009) 87-95
39. Saito M., Miura Y., Notani K., and Kawasaki T. Stress distribution of abutments and base displacement with precision attachment- and telescopic crown-retained removable partial dentures. J Oral Rehabil 30 (2003) 482-487